Summary We examined the expression of al, a2, a3, a4, a5 and ,B1 integrin on 36 transitional cell cancers (TCCs) in the bladder by immunohistochemistry. Only a2, a3 and /31 were detected on normal transitional cell epithelium, but four TCCs (12.5%) revealed positive staining for al, seven (19.4%) for a4 and seven (20%) for a5. These altered expressions of integrin a chain were more frequent in histologically higher stage or grade of TCC, and a correlation was found between increased aS expression and histological stage. ae5 was positive in 6 (35.3%) of 17 invasive TCCs whereas only 1 (5.9%) of 17 superficial TCCs. Flow cytometric analysis on bladder cancer cell lines showed that T24 and HT1376, which are undifferentiated TCC cell lines, highly expressed aS and P1. Also, SCaBER, which is derived from urinary bladder squamous cell cancer and which is recognised as the most malignant phenotype after metaplasia of transitional epithelium, had aS and P1.
In the process of tumour invasion and metastasis, the interaction between tumour cells and extracellular matrix (ECM), such as laminin, fibronectin and collagens, has a crucial role (Nicolson and Winkelmake, 1975; Horn and Tang, 1992) . This interaction is facilitated through adhesion receptors such as integrins. Integrins are a family of cellsurface proteins that mediate cell adhesion to ECM and signal transduction to the cell interior (Hynes, 1990; Albelda, 1993) . They are composed of two subunits, a and ,B, each of which spans the plasma membrane. Distinct a-subunits combine with common or related fl-subunits to form functionally distinct receptors.
Integrin distributions have been studied in a number of tissues, including malignant tumours. Recent studies showed that patterns of integrin expression on tumour cells were different compared with normal counterparts and suggested that altered integrin expression may contribute to the invasive or metastatic phenotype. For example, the loss of integrin expression was reported in epithelial neoplasms, such as carcinomas of the breast, colon, pancreas and skin (Pignatelli et al., 1990; Zutter et al., 1990; Hall et al., 1991; Stamp and Pignatelli, 1991) . On the other hand, up-regulation of aV#3 was described in malignant melanoma and glioblastoma multiforme, and acquisition of a4#1 has been described in malignant melanoma and renal cell carcinoma (Cheresh et al., 1989; Gladson and Cheresh, 1991; Tomita et al., 1995) . In transitional cell carcinoma (TCC), progressive loss of a2 integrin expression from normal urothelial cells through invasive cancers was reported and some a5 integrin was expressed on high stage TCC (Leibert et al., 1994) .
VLA-5 (a5fl1 integrin) is a fibronectin receptor whose expression is often reduced in tumour cells (Plantefaber and Hynes, 1989) . In addition, increasing the expression of the a5,Bf integrin by gene transfer decreases the formation of tumours on Chinese hamster ovary cells, suggesting the presence of VLA-5 on tumour cells might be a disadvantage for their proliferation (Giancotti and Ruoslahti, 1990) . Indeed, after transfection, they showed less migratory, reacquired features of normal growth control in culture, resulting in lost ability to form tumours when injected subcutaneously into nude mice (Giancotti and Ruoslahti, 1990) . Several other studies, including some on human tumour cells, confirmed the correlation between low VLA-5 expression and malignant transformation or higher malignant potential (Varner et al., 1992; Witkowski et al., 1993) .
The expression of VLA-5 on high stage TCC in a previous report seemed curious. Therefore, we focused our interest on the expression of VLA-5 on TCC and the normal transitional cell and its mRNA. We examined the expression of integrins on 36 TCCs and six normal transitional cells by immunohistochemistry. Flow cytometric analysis and RT-PCR for VLA-5 or mRNA of x5 integrin on bladder cancer cell lines and normal transitional cell line were also performed. We showed that the presence of VLA-5 might indicate a more malignant phenotype, as for TCC.
Materials and methods Tissue specimens
Tumour specimens were obtained from 36 patients (25 males and 11 females) who had undergone total cystectomy or transurethral resection for bladder cancer. The mean age at the time of operation was 67.9 years, ranging from 41 to 84 years. Six specimens of normal urinary bladder epithelium were collected from a histologically unaffected portion of the bladder. Tissue samples were embedded in an optimum cold temperature compound (Miles Laboratories, Naperville, IL, USA) and were quickly frozen in isopentane, precooled in dry ice acetone. These blocks were stored at -80°C until 5 gm serial sections were cut using a cryostat. Histological examination was performed on haematoxylin and eosinstained tissue sections. Tumours were graded and staged according to the criteria of the World Health Organization.
Reagents
Monoclonal antibodies (MAbs) used in this study were as follows: TS2/7 against axl, P1E6 against cx2, PlB5 against a3, P4G9 against x4, P1D6 against a5, 4B4 against #1.
Polyclonal anti-a5 antibody AB1928 was also used. These MAbs were purchased from Telious Pharmaceuticals (San Diego, CA, USA), except for 4B4 which was purchased from Corter (Hialeah, FL, USA) and AB1928, which was 328 purchased from Chemicon International (Temecula, CA, USA). Optimal dilution for each antibody was determined by staining specimens of lymph nodes obtained during nephrectomy for renal cell carcinoma without tumour metastasis.
Immunoperoxidase staining Immunoperoxidase staining was performed using the streptavidin-biotin bridge technique as described previously (Tomita et al., 1990) . Briefly, serial sections were air dried and fixed in cold acetone. After rehydration with phosphatebuffered saline (PBS), sections were incubated in PBS containing 20% normal sheep serum (Antibodies, Davis, CA, USA) for 30 min, and endogenous biotin was blocked using an endogenous biotin blocking kit (Vector Laboratories, Burlingame, CA, USA). and /B1 integrin on bladder TCC as well as normal transitional epithelium. When normal transitional cell epithelium was stained with the panel of MAbs, only a2, oc3 and /11 were positive. On the other hand, some TCCs expressed a 1, a4 and a5, and these altered expressions of integrins were observed relatively frequently in the higher grade and/or stage tumours. These results suggest that increased expression of al, a4 and a5 might change the character of TCC to ECM and facilitate tumour invasion or metastasis. Also, a significant correlation was found only between increased a5 expression and the histological stage. Leibert et al. (1994) also showed that a5 integrin was expressed on high-stage TCC but not on low-stage tumours. However, a5 was detected on TCC in a rather smaller number of tumours than in the present study, and there was no positive staining of a4. These discrepancies may be explained by the difference in staining methods and/or MAbs used. We might use a possibly more sensitive staining procedure, amplifying positive staining by the streptavidinbiotin system, which we used in other studies (Tomita et al., 1990 (Tomita et al., , 1993 .
A member of the integrin /1 subfamily, VLA-5 (a5fll), is a fibronectin receptor, and its expression is often reduced in tumour cells (Plantefaber and Hynes, 1989) . In addition, increase in a5#1 expression by gene transfection decreases the formation of tumours on Chinese hamster ovary cells, suggesting that the presence of VLA-5 on cells might be a disadvantage for tumour cell proliferation by transducing growth-inhibitory stimuli from fibronectin (Schreiner et al., 1991) . Indeed, after transfection, they showed less migration and reacquired the features of normal growth control in culture, resulting in loss of the ability to form tumours when injected subcutaneously into nude mice (Giancotti and Ruoslahti, 1990 (Terpe et al., 1993; Leibert et al., 1994) . Interestingly, HTB 160, which is a normal TCC line, showed positive staining against a5. However, HTB160 was developed from fetal bladder. It is possible that the expression of integrin is different between adult and fetal bladder because its expression is reported to be different between adult and fetal kidney (Korhonen et al., 1990 ).
In conclusion, we have shown the significance of the expression of integrins on bladder transitional cell cancer, especially the correlation between VLA-5 and malignant behaviour of TCC cells. Although the functional aspect of these results are still unclear, integrins, especially VLA-5, might have important roles in the invasion and metastasis of transitional cell cancer.
VLA-5 expression and malignant transformation or a higher malignancy (Varner et al., 1992; Witkowski et al., 1993) .
The present study on TCC, however, showed a more frequent expression of ocS and ,B1 chain on TCCs of higher grade and histopathological stage. In addition, examination 
